CAPRICOR THERAPEUTICS, INC. (CAPR)

Every figure this model derived for CAPR, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 10,905,360 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 237,934,782 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 242,127,977 AssetsCurrent 2026-06-30
current liabilities 32,961,421 LiabilitiesCurrent 2026-06-30
equity 246,218,890 StockholdersEquity 2026-06-30
interest expense 3,045,725 InterestExpenseNonoperating 2025-12-31
ocf -103,995,608 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 0 Revenues 2025-12-31
sbc 17,225,260 AllocatedShareBasedCompensationExpense 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up CAPR on one particular measure came for.

RatioValue
current ratio11.55
current ratio reported7.35
deferred revenue growth0.0
dilution pct32.0
growth cv1.39
interest cover-44.38
revenue growth-100.0
revenue growth per share-100.0
roic-1288.92

What to be careful about

What this model itself distrusts about CAPR's figures. Written by the derivation as it ran, not added afterwards.